Suchergebnisse - "Zenz, Thorsten"

PubPharm (12)

1

R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK) : final results of a multicentre, phase 3, open-label, randomised trial

enthalten in: The Lancet. Haematology | 2023

von Chamuleau, M. | Stenner, F. | Chitu, D. | +28

2

Genetic and phenotypic attributes of splenic marginal zone lymphoma

enthalten in: Blood | 2022

von Bonfiglio, F. | Bruscaggin, A. | Guidetti, F. | +94

CommentIn: Blood. 2022 Feb 3;139(5):644-645. - PMID 35113148

3

Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia

enthalten in: Leukemia | 2019

von Jebaraj, B. | Tausch, E. | Landau, D. | +20

4

New lessons learned in T-PLL : results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance

enthalten in: Leukemia & lymphoma | 2019

von Pflug, N. | Cramer, P. | Robrecht, S. | +15

5

TP53 mutation and survival in aggressive B cell lymphoma

enthalten in: International journal of cancer | 2017

von Zenz, T. | Kreuz, M. | Fuge, M. | +19

6

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

enthalten in: Blood | 2016

von Mansouri, L. | Noerenberg, D. | Young, E. | +52

CommentIn: Blood. 2016 Dec 8;128(23 ):2591-2592. - PMID 27932324

7

Gene mutations and treatment outcome in chronic lymphocytic leukemia : results from the CLL8 trial

enthalten in: Blood | 2014

von Stilgenbauer, S. | Schnaiter, A. | Paschka, P. | +29

CommentIn: Blood. 2014 May 22;123(21):3212-4. - PMID 24855188

8

NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab : results from the CLL2H trial of the GCLLSG

enthalten in: Blood | 2013

von Schnaiter, A. | Paschka, P. | Rossi, M. | +13

9

Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia : a multivariate analysis from the randomized GCLLSG CLL8 trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2012

von Böttcher, S. | Ritgen, M. | Fischer, K. | +13

10

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia : long-term clinical and MRD results of the German CLL Study Group CLL3X trial

enthalten in: Blood | 2010

von Dreger, P. | Döhner, H. | Ritgen, M. | +43

CommentIn: Nat Rev Clin Oncol. 2011 Jan;8(1):3. - PMID 21218528